The role of vascular cell adhesion molecule-1 in tumor immune evasion
1Department of Pathology, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA. wutc@jhmi.edu
Abstract:
Tumor immune escape is a critical trait of cancer but the mechanisms involved have yet to fully emerge. One recent study has shown that tumor cells can escape T-cell immunity by overexpressing the endothelial cell adhesion molecule vascular cell adhesion molecule-1 (VCAM-1), which normally mediates leukocyte extravasion to sites of tissue inflammation. Renal cell carcinoma (RCC) was identified as one tumor type where VCAM-1 is commonly highly overexpressed. Together, our findings suggest that RCCs might exploit VCAM-1 overexpression for immune escape.
Insights
Cancer cells can evade immune T-cells by overexpressing vascular cell adhesion molecule-1 (VCAM-1). This study found that renal cell carcinoma (RCC) commonly overexpresses VCAM-1, suggesting a mechanism for immune evasion.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Tumor immune escape is a significant challenge in cancer treatment.
- Mechanisms by which tumors evade immune surveillance are not fully understood.
- Vascular cell adhesion molecule-1 (VCAM-1) is involved in leukocyte extravasation.
Purpose of the Study:
- To investigate the role of VCAM-1 in tumor immune escape.
- To determine if VCAM-1 overexpression is present in renal cell carcinoma (RCC).
Main Methods:
- Analysis of VCAM-1 expression in tumor cells.
- Correlation of VCAM-1 levels with immune evasion markers.
Main Results:
- Tumor cells can overexpress VCAM-1 to escape T-cell immunity.
- VCAM-1 is frequently overexpressed in renal cell carcinoma (RCC).
Conclusions:
- VCAM-1 overexpression represents a potential mechanism for immune escape in RCC.
- Targeting VCAM-1 may offer new therapeutic strategies for RCC.
Related Concept Videos
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved...
The Tumor Microenvironment
Tumor Immunotherapy
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Cell Migration through Invadopodia
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...


